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ABSTRACT Parameters of bone geometry such as width, length, and cross-sectional area are major de-
terminants of bone strength. Although these traits are highly heritable, few genes influencing bone
geometry have been identified. Here, we dissect a major quantitative trait locus (QTL) influencing femur
size. This QTL was originally identified in an F2 cross between the C57BL/6J-hg/hg (HG) and CAST/EiJ
strains and was referred to as femur length in high growth mice 2 (Feml2). Feml2 was located on chromo-
some (Chr.) 9 at 20 cM. Here, we show that the HG.CAST-(D9Mit249-D9Mit133)/Ucd congenic strain
captures Feml2. In an F2 congenic cross, we fine-mapped the location of Feml2 to an 6 Mbp region
extending from 57.3 to 63.3 Mbp on Chr. 9. We have identified candidates by mining the complete
genome sequence of CAST/EiJ and through allele-specific expression (ASE) analysis of growth plates in
C57BL/6J · CAST/EiJ F1 hybrids. Interestingly, we also find that the refined location of Feml2 overlaps a
cluster of six independent genome-wide associations for human height. This work provides the foundation
for the identification of novel genes affecting bone geometry.
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Osteoporosis is a disease of severe bone loss that leads to skeletal fragility
and an increased risk of fracture (Black and Rosen 2016). In the U.S.,
osteoporosis affects over 12 million people and is directly responsible
for 1.5 million fractures annually (Black and Rosen 2016). Although
fracture is not commonly associated with mortality, of the 300,000
people each year that suffer a hip fracture, one in five will die in the
subsequent 12 months (Gass and Dawson-Hughes 2006).
Bone geometry is one of the many factors that contribute to bone
strength (Bouxsein and Karasik 2006). Studies in mice have demon-
strated that up to 50% of the variance in bone strength is due to bone
size (Ng et al. 2007). Furthermore, the relationship between bone ge-
ometry and fracture risk in humans has been demonstrated in both the
wrist and the spine, as decreased cross-sectional area of the radius and
vertebrae are associated with increased risk of fracture (Bouxsein and
Karasik 2006). In addition, similar tomost other characteristics of bone,
bone geometry is highly heritable (h2. 0.50) and amenable to genetic
analysis (Norgard et al. 2008). Therefore, increasing our understanding
of the genes influencing bone geometry using genetic analyses has the
potential to inform strategies for the treatment and prevention of bone
fragility.
To identify QTL affecting body composition, Corva et al. (2001)
generated an F2 cross between the C57BL/6J-hg/hg (HG) and
CAST/EiJ (CAST) strains. The HG strain is a C57BL/6J (B6) mouse
that is homozygous for a deletion encompassing the Socs2 gene [the
high growth (hg) locus], a negative regulator of growth hormone
signaling, that results in increased growth and body size (Metcalf
et al. 2000; Horvat and Medrano 2001). In contrast, CAST mice are
genetically divergent wild-derived inbred mice that are small and
lean. One QTL identified in the hg · CAST cross was Feml2. Feml2
was located on Chr. 9 at 20 cM, explained 10.7% of the variance in
femur length, and was independent of the hg locus (Corva et al.
2001). In order to identify the gene(s) responsible for Feml2,
we generated the HG.CAST-(D9Mit249-D9Mit133)/Ucd (HG9)
congenic strain that possessed CAST alleles from 9 to 84 Mbp on
an HG background (Farber et al. 2006). The HG9 strain has pre-
viously been used to fine-map a distinct QTL affecting adiposity
(Farber et al. 2009).
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In the current study, twoHG9 F2 intercrosses were used tofine-map
Feml2. We used the complete genome sequences of the B6 and CAST
strains and ASE analysis of B6 · CAST F1 mice to identify candidate
genes driving the effect on femur length. Interestingly, the human
syntenic region contains a cluster of six genome-wide associations with
human height. These data provide the foundation to identify genes
contributing to bone size and geometry.
MATERIALS AND METHODS
Mouse strains and husbandry
The mouse strains used in the study were B6, HG, and the HG9
(MGI:3771219) congenic strain. The development of the HG and
HG9 congenic strains have been previously described (Horvat and
Medrano 1995; Farber et al. 2006). B6 and HG mice were obtained
from vivarium stock. Mice were provided with a normal chow diet
(Purina 5008; 23.5% protein and 6.5% fat, 3.3 Kcal/g) and water ad
libitum, and housed in groups of 2–5 in polycarbonate cages bedded
with a 2:1 mixture of CareFRESH (Absorption, Ferndale, WA) and
soft paper chips (Canbrands, Moncton, Canada). Mice were main-
tained under controlled conditions of temperature (216 2), humidity
(40–70%), and lighting (14 hr light, 10 hr dark, lights on at 7 AM). All
mouse protocols were managed according to the guidelines of the
American Association for Accreditation of Laboratory Animal Care
(AAALAC) and approved by the Institutional Animal Care and Use
Committee at the University of California, Davis.
Characterization of bone geometry in HG9
congenic mice
At 9 wk of age (6 5 d), male HG9 congenic (N = 7) and HG control
(N = 14) mice were anesthetized and body weights and lengths were
measured to the nearest decigram and centimeter, respectively. Mice
were then killed and femurs were removed and cleaned of soft tissue.
For each femur, we measured the length and width, in the medio-
lateral and anterior–posterior orientations, using digital calipers
(Mitutoyo Corporation, Takatsu-ku, Japan). Experimenters were
blinded to the genotype of the mice.
Development and characterization of the HG9F2
mapping populations
The congenic F2 mouse populations used in this study have been
described in (Farber et al. 2009). Briefly, HG9 · HG (N = 283) and
HG9 · B6 (N = 457) male and female F2 mice were generated by
intercrossing F1 mice. F2 mice were phenotyped as described above
for HG9 congenics. Mice were genotyped using microsatellite markers.
HG9 · B6 F2 mice were genotyped for the hg locus as described in
Farber et al. (2006).
Feml2 fine-mapping
All statistical analyses were performed using the R Language and
Environment for Statistical Computing (R Development Core Team
2013). The R/qtl package was used to perform the linkage anal-
ysis (Broman et al. 2003). Sex-averaged genetic maps were gen-
erated and conditional genotype probabilities were estimated
using the calc.genoprob function, along the length of the con-
genic donor region at 0.1 cM intervals. Both F2 crosses were
combined for the linkage analysis. The scanone function, using
the Haley–Knott regression algorithm, was used to perform in-
terval mapping using a model that included sex, body weight, and
cross type (HG9 · HG = 1 or HG9 · B6 = 2) terms as additive
covariates. LOD significance for all models tested were empirically
n Table 1 Characterization of femur geometry in male HG and HG9 mice
HG (N = 14) HG9 (N = 7) Difference (%) (HG9 – HG/HG) P-Value
Femur length (mm) 17.2 6 0.1 16.2 6 0.1 26 1.3 · 1025
Mediolateral femur width (mm) 2.41 6 0.04 2.28 6 0.02 26 2.1 · 1023
Anterior–posterior femur width (mm) 1.55 6 0.05 1.45 6 0.02 27 3.7 · 1022
Figure 1 Feml2 LOD score profiles. Vertical lines
indicate peak LOD scores. The peak of Feml2 was
located at 30.1 cM in the HG9 · HG (N = 283) cross
(A), 30.0 cM in the HG9 · B6 (N = 457) cross (B), and
30.1 cM in both crosses combined (N = 740). The
95% C.I. for the location of Feml2 in the combined
cross was 28.3–31.7 cM (57.6–63.3 Mbp) (C). Feml2
had highly significant effects (P , 0.001) on femur
length in both male and female mice (D). LOD, log-
arithm of the odds.
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determined using 1000 permutations. We converted genetic to
physical distance by regressing megabase pairs onto centimorgans
for all markers.
Growth plate RNA collection
Sevenmale F1s from a cross betweenB6 andCASTwere killed at 21 d of
age by isoflurane anesthesia followed by cervical dislocation. Proximal
and distal tibial growth plates were rapidly dissected, placed in TRIzol
(Ambion by Life Technologies) and pulverized using the Tissue Tearor
homogenizer (BioSpec Products). Total RNA was extracted from ho-
mogenized tissue (mirVana miRNA Isolation Kit, Ambion by Life
Technologies). RNA concentration was measured by fluorometry
(Qubit 2.0 Fluorometer, Life Technologies).
RNA-sequencing (RNA-seq) sample preparation
RNA-seq libraries were constructed from 200 ng of total RNA using
Illumina TruSeq Stranded Total RNA with Ribo-Zero Gold sample
prep kits (Illumina, Carlsbad, CA). Constructed libraries contained
RNAs. 200 nucleotides (both unpolyadenylated and polyadenylated)
and were depleted of cytoplasmic and mitochondrial rRNAs. An
average of 6.7 million 2 · 75 bp paired-end reads were generated
for each sample on an Illumina NextSequation 500 (Illumina).
RNA-seq alignment strategy and ASE analysis
Alleles was generated sing g2gtools (Choi 2016a), a transcriptome con-
taining both B6 (mm 10) and CAST [mm10 with version 4 single
nucleotide polymorphisms (SNPs) and insertion/deletions (indels)
from the Mouse Genome Project http://www.sanger.ac.uk/science/
data/mouse-genomes-project]. Reads from each F1 hybrid were aligned
to the joint transcriptome using Bowtie, allowing no more than 3 mis-
matches and reporting all alignments of the stratum containing the
fewest number of mismatches (Langmead et al. 2009). Next, EMASE
(Choi 2016b) was used to quantify the number of reads from both the
maternal and paternal allele. Each end of the paired-end samples was
processed separately and only reads aligning in both samples were
included. Similarly, each lane was processed separately in order to
correct for lane-specific effects. Postquantification, all samples passed
quality control checks based on the expected global proportions of
reads aligning to each parental strain. All samples showed nearly equal
reads mapping to each parental strain. In order to identify genes show-
ing allelic expression, edgeR was used to compare the quantity of each
transcript by strain across the seven samples. Only those transcripts
with measured expression in at least one haplotype in all of the samples
were included in ASE analysis. The glmFit and glmLRT functions were
used to statistically compare the expression of each transcript between
the CAST and B6 alleles.
Additional statistical analyses
Bone geometry measures in HG9 congenic and HG control mice were
compared using a Student’s t-test in R (R Development Core Team
2013). Comparisons at a P , 0.05 were deemed significant. Permuta-
tion analysis was used to determine the probability of six GWAS asso-
ciations for height occurringwithin the 7.5Mbp human region syntenic
with Feml2 by randomly selecting 1000 7.5 Mbp regions from the
genome and counting the number of associations within each region.
Genome-wide significant SNPs identified through a GWAS for human
height were mapped to mm10 from hg18 using the liftover tool from
UCSC.
Data availability
Both C57BL/6J and CAST/EiJ strains are commercially available from
Jackson Labs. SupplementalMaterial, File S1 containsR/QTL formatted
mapping information, including mouse IDs, phenotype information,
and SNP marker identifiers, locations, and genotypes (A=C57BL/6J,
B=CAST/EiJ) (File S1). Phenotype information can be found in the
accompanying README file (File S2). Gene expression data from
chondrocytes are available at GEO with the accession number
GSE90055.
RESULTS
Feml2 is captured in HG9 mice
Wecharacterized femurgeometry inHG9andHGmalemice.As shown
in Table 1, femur length was decreased by 6% (P = 1.3 · 1025) in HG9
n Table 2 List of SNPs located within Feml2
Variant Number
Noncoding
Downstream gene variant 1993
Upstream gene variant 2230
Intergenic variant 20,949
Intron variant 20,452
Splice region variant 40
Total 45,664
Coding
39-UTR variant 523
59-UTR variant 51
Synonymous variant 246
Missense variant 81
Initiator codon variant 1
Stop gained 3
Stop retained 1
Mature miRNA variant 1
Noncoding exon variant 53
Total 960
UTR, untranslated region; miRNA, microRNA.
n Table 3 Allele-specifically expressed genes from the Feml2 region
Gene Name Chr. Gene Start–End
CAST/EiJ
Mean tpm
C57BL/6J
Mean tpm
CAST/EiJ
Mean Eff. Counts
C57BL/6J
Mean Eff. Counts logFC
a P-Value FDR
Gramd2 9 59,680,144–59,718,874 5.11 4.22 534 339 0.69 0.002 0.11
Larp6 9 60,712,989–60,738,801 2.13 1.40 216 142 0.64 0.005 0.11
Adpgk 9 59,291,572–59,316,199 5.66 8.72 586 893 20.60 0.013 0.13
Ubl7 9 57,910,986–57,929,968 4.49 3.14 247 174 0.54 0.012 0.13
Rec114 9 58,652,850–58,743,964 2.12 1.04 43 19 1.09 0.008 0.13
Glce 9 62,057,248–62,122,655 2.06 1.46 341 254 0.49 0.021 0.17
Chr., chromosome; tpm, transcripts per million; Eff., effect; FDR, false discovery rate.
a
Positive logFC values correspond to favored CAST/EiJ expression, while negative logFC values correspond to favored C57BL/6J expression.
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males, consistent with the effects of Feml2 in the original F2 cross
(Corva et al. 2001). In addition, mediolateral and anterior–posterior
femur widths were also decreased by 6–7% (P = 2.1 · 1023 and P =
3.7 · 1022, respectively) in HG9 males (Table 1). These data confirm
the capture of Feml2 in the HG9 congenic interval.
High-resolution mapping of Feml2
To refine the location of Feml2 within the HG9 congenic interval,
we generated two F2 crosses, HG9 · HG (N = 283) and HG9 · B6
(N = 457). Femur length was first mapped in each cross separately. No
differences in the LOD score profile of peak positions were observed
(Figure 1, A and B). As a result, both crosses were combined to increase
mapping resolution (Figure 1C). Feml2mapped to 30.1 cMwith a peak
LOD score of 40.0 (Figure 1C). The effects of Feml2 on femur length
were additive with each CAST allele decreasing femur length by
0.23 mm (Figure 1D). Feml2 explained 7.8% of the total variance in
femur length. The 95% C.I. for Feml2 extended from 28.0 to 31.7 cM,
which in physical distance equated to the 5.7 Mbp region extending
from 57.6 to 63.3 Mbp (GRCm38/mm10).
Characterizing Feml2 variants between CAST and B6
Feml2 contains a total of 69 RefSeq protein-coding genes (Table S1).
Based on the sequenced CAST genome (Keane et al. 2011), Feml2
contains 46,624 high-confidence SNPs between CAST and B6. Most
(45,664; 97.9%) of the SNPs are noncoding (Table 2). There are
960 (2.1%) coding variants, of which 86 are potentially “high-impact.”
Of these 86, there are 81 missense, one initiator codon, three stop-
gained, and one stop-retained variants (Table 2). Potentially high-
impact variants were found in 37 of the 69 Feml2 genes. The initiator
codon variant is in the enhancer of mRNA decapping 3 (Edc3) gene;
however, a second in-frame “ATG” is located 6 bp downstream.
Two of the stop-gain and the stop-retained variants were found in
the “unclassified” gene 1700036A12Rik. The other stop-gain variant
was in another “unclassified” gene, Gm10657 (Table S1).
In addition to SNPs, there were 8803 small indels. There were
189 indels in untranslated regions (UTRs), two frameshifts, and one
in-frame insertion.The restwere intergenic.The two frameshift variants
were found in Arid3b and Nptn; however, both occurred in exons
predicted by Ensembl that were not part of the RefSeq transcript for
Figure 2 Boxplots of the expres-
sion of six genes demonstrating
significant (FDR , 0.20) allele-
specific expression differences.
Expression is expressed in units
of transcripts per million (tpm)
and binned by strain of origin.
FDR, false discovery rate.
Figure 3 UCSC Genome Browser view of mm10 Chr. 9:57300000–63300000, which comprises the Feml2 locus. The uppermost track displays
potential high-impact predicted coding polymorphisms between CAST and B6 (black = missense, green = initiator codon variant, and purple =
stop gained and stop retained variants). The second uppermost track (blue) contains SNPs homologous to those identified in a GWAS for human
height (Wood et al. 2014), which may play a regulatory role in gene expression that influences femur length. Finally, the bottom-most track
displays the genes within the Feml2 region. In red are genes that exhibited significant (FDR , 0.20) differences in allele-specific expression. FDR,
false discovery rate; GWAS, genome-wide association study; SNP, single nucleotide polymorphism; UCSC, University of California, Santa Cruz.
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either gene. The in-frame insertion was also found in the Arid3b gene
and did occur with a RefSeq exon.
Characterizing Feml2 ASE using CAST 3 B6 F1 RNA-
seq data
To identify Feml2 genes whose expression is under genetic regulation,
we quantified ASE in growth plate tissue in CAST · B6 F1 mice. Six of
the 69 genes from the Feml2 region were found to be expressed in an
allele-specific manner, demonstrating higher transcript levels originat-
ing from either the B6 or CAST chromosomes in growth plate samples
at an FDR , 0.20 (Figure 3 and Table 3). These genes are GRAM
domain containing 2 (Gramd2), La Ribonucleoprotein Domain Family
Member 6 or Acheron (Larp6), ADP-Dependent Glucokinase (Adpgk),
Bone Marrow Stromal Cell-Derived Ubiquitin-Like 7(Ubl7), Meiotic
Recombination Protein REC114-Like (Rec114), and Heparin/Heparan
Sulfate:Glucuronic Acid C5-Epimerase (Glce). All of these genes, except
for Adpgk, were preferentially expressed from the CAST allele as com-
pared to the B6 allele (Figure 2).
Feml2 overlaps with a cluster of human height genome-
wide associations
Given the significant impact of Feml2 on femur length, it is possible that
Feml2 harbors multiple independent variants impacting skeletal di-
mensions. To determine if there is evidence that Feml2 represents a
“hot-spot” of genes influencing long bone size, we analyzed the syntenic
region of the human genome for human height associations (which are
often driven by changes in skeletal dimensions) (Soranzo et al. 2009)
identified by GWAS (Wood et al. 2014). Feml2 is syntenic with human
Chr. 15 from 67.5 to 75.5 Mbp. This region contains six independent
associations as identified by GWAS for human height (Wood et al.
2014) (Figure 3). Through permutation, there was suggestive evidence
that the human region syntenic with Feml2 contained more associa-
tions for height than would be expected by chance (P = 0.06). Addi-
tionally, these SNPs were found to be near the human homologs of all
six genes exhibiting allelic expression (Table 4).
DISCUSSION
As a first step in identifying the gene(s) responsible for a QTL with a
major effect on bone geometry, we developed a congenic strain con-
taining the Feml2 QTL and conducted an F2 intercross to refine the
location of Feml2. Furthermore, we used the CAST and B6 genome
sequences to identify genes within Feml2 potential impact by coding
variation. Consistent with the high polymorphism rate between CAST
and B6 (Keane et al. 2011), 37 of the 69 Feml2 genes contained coding
variants predicted to potentially impact protein function (Table 2).
Additionally, we hypothesized that noncoding variants between CAST
and B6 could be driving expression differences between the two strains,
and that this change in expression could be responsible for the reduced
femur length in CAST mice. Using RNA-seq data from tibial growth
plates of CAST · B6 F1s, we identified six of the 69 genes in the Feml2
region that are preferentially expressed from one parental allele.
Of thegenes influencedbyASE,wenote two thathave thepotential to
be driving the observed femur length phenotype based on their known
biological function. Larp6, also known as Acheron, is an RNA-binding
protein that is specific to collagen mRNAs (Stefanovic et al. 2014).
Larp6 regulates the translation of type I collagen subunits through
sequence-specific binding to conserved stem loops in the 59-UTRs
of collagenmRNAs (Zhang and Stefanovic 2016). Collagens, predom-
inantly type I collagen, comprise 90% of the bone matrix and their
processing is critical for proper skeletal development (Young 2003). It
has been observed that overexpression of Larp6 blocks ribosomal
loading onto collagen mRNAs, reducing translation of collagen and
bone matrix formation (Cai et al. 2010). In CAST · B6 F1s, the
expression of Larp6 was higher from the CAST allele, potentially
consistent with shorter femurs in HG9 mice. Adpgk, also known
as ADP-dependent glucokinase, catalyzes the phosphorylation of
D-glucose to D-glucose-6-phosphate using ADP as the phosphate
donor (Richter et al. 2012). Knockouts of Adpgk result in short stature
and slender bones (Skarnes et al. 2011). In CAST · B6 F1s, the ex-
pression of Adpgk was lower from the CAST allele, consistent with
shorter andmore slender femurs in HG9mice. The ASE of these genes
suggests that they may be involved in the regulation of femur length.
We identified the human syntenic region for Feml2, and found that
it contained a number of associations for human height identified
throughGWAS.Humanheight is partly influenced by long bone length
(Lui et al. 2016), and this well-powered GWAS, conducted by Wood
et al. (2014), provides a robust collection of loci associated with human
height to compare with the Feml2 region’s influence on mouse long
bone length. This human region appears to be a hotspot for associations
with height, further implicating the murine region as a region influ-
encing femur length and, more generally, skeletal dimension (Figure 3).
Further characterization of the genes in the mouse Feml2 region is
potentially applicable to the study of human height.
In conclusion, this study identified Feml2, a region of the murine
genome influencing femur length, and identified genes with coding and
regulatory alterations, a subset of which may be responsible for the
effects of Feml2. Additionally, comparisons with its human syntenic
region support the notion that Feml2 may contain multiple polymor-
phic genes, which in aggregate are responsible for its effect on bone
geometry. Further characterization of these candidate genes and the
identification of the mechanism by which they alter femur dimension
will aid in the study of bone geometry and bone strength.
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